Trends and disparities in mortality involving secondary malignant neoplasm of the lung in the United States, 1999–2024: a serial cross-sectional multiple-cause-of-death analysis
This serial cross-sectional analysis of US mortality data from 1999 to 2024 reveals that while deaths involving secondary malignant neoplasm of the lung initially declined, rates have risen since 2008 to reach historic highs in 2024, accompanied by shifting demographic and geographic disparities that warrant further investigation into underlying causes such as changes in survival, detection, or documentation practices.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Cancer is often thought of as a single disease that starts in one place, but for many patients, the true threat comes from how it spreads. When cancer cells break away from their original home and travel through the blood or lymph system to settle in other organs, this is called metastasis. The lungs are a frequent destination for these wandering cells, acting as a common stopover for cancers that began in the colon, breast, or skin. While doctors have long known that metastatic disease is the primary cause of cancer deaths, tracking exactly how often the lungs are involved has been difficult. Cancer registries usually focus on where a tumor started, often missing the details of where it ended up. To understand the full picture of how these diseases kill, researchers must look at death certificates, which can list every condition present at the end of a life, not just the main cause. This broader view allows scientists to see patterns in how metastatic lung disease affects different groups of people over time.
A team of researchers recently took a deep dive into this specific pattern using a massive database of death records from the United States. They examined every death certificate from 1999 to 2024 that mentioned a secondary malignant neoplasm of the lung, a medical term for cancer that has spread to the lungs from somewhere else in the body. By analyzing more than half a million records, they were able to map out how the frequency of these deaths has changed over a quarter of a century. Their work reveals a story of two distinct eras. For the first decade of the study, the rate of deaths involving lung metastasis actually went down, reaching its lowest point in 2008. However, the trend reversed sharply after that year. Since 2008, the number of deaths involving cancer that had spread to the lungs has climbed steadily, rising to its highest recorded level in 2024.
The researchers were careful to ensure this rise was not just an illusion caused by doctors writing more details on death certificates. They compared the number of lung metastasis mentions against the total number of cancer deaths, which actually dropped significantly over the same period. Because the total number of cancer deaths fell while the mentions of lung metastasis rose, the increase cannot be explained simply by better record-keeping. Instead, the data suggests a real shift in the landscape of the disease. The rise was not felt equally across the country or among all people. The increase was most dramatic among the very oldest adults, those over 85, and surprisingly, it also showed a sharp rise among young adults between the ages of 25 and 34. In contrast, the middle-aged groups saw much smaller changes.
Geography played a major role in these findings as well. In 1999, the western United States had the lowest rate of these deaths, but by 2024, it had the highest. The gap between people living in cities and those in rural areas also widened, with rural areas seeing a more significant increase. The study also uncovered a shift in racial patterns. For decades, non-Hispanic Black adults had the highest rates of death involving lung metastasis. However, the trend for this group flattened out in recent years, while the rates for non-Hispanic White adults continued to climb, eventually surpassing the Black population. This reversal suggests that the factors driving these deaths are changing in complex ways that affect different communities differently.
The researchers considered several reasons for this upward trend. It could be that treatments for the original cancers are working better, allowing patients to live longer with the disease, which gives metastasis more time to develop and be recorded. It could also be that modern imaging technology is finding these lung deposits earlier and more often than in the past. However, the study does not have the data to prove which of these factors is the primary driver. What is clear is that the burden of this specific type of cancer death has grown, particularly for the very young and the very old, and that the patterns of who is dying and where are changing rapidly. This work highlights the need to look beyond the primary cause of death to understand the full scope of the cancer crisis, showing that while we may be winning battles against some cancers, the war against metastatic spread is entering a new and challenging phase.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.